Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng-Cheng Lv

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Expert Opinion on Therapeutic Patents|November 20, 2014
EGFR-binding peptide: a patent evaluation of WO2014002836Peng-Cheng Lv, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|February 3, 2015
Nitroimidazole derivatives: a patent review of US 2014/0141084 A1Peng-Cheng Lv, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|December 16, 2016
Tyrosyl-tRNA synthetase inhibitors: a patent reviewJuan Sun, Peng-Cheng Lv, Hai-Liang Zhu
Current Medicinal Chemistry|December 3, 2014
Recent advances of p53-MDM2 small molecule inhibitors (2011-present)Peng-Cheng Lv, Juan Sun, Hai-Liang Zhu
Bioconjugate Chemistry|July 1, 2016
Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing CancersPeng-Cheng Lv, Karson S Putt, Philip S Low
Current Topics in Medicinal Chemistry|September 19, 2019
Recent Progress in the Development of Small Molecule c-Met InhibitorsPeng-Cheng Lv, Yu-Shun Yang, Zhong-Chang Wang
Current Medicinal Chemistry|November 3, 2016
Recent Advances in the Design and Synthesis of c-Met Inhibitors as Anticancer Agents (2014-Present)Peng-Cheng Lv, Zhong-Chang Wang, Hai-Liang Zhu
Archiv Der Pharmazie|March 17, 2010
Design, synthesis, and pharmacological investigation of iodined salicylimines, new prototypes of antimicrobial drug candidatesSuo-Ping Xu, Peng-Cheng Lv, Lei Shi, et al.
Molecular Pharmaceutics|April 5, 2016
Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic TumorsPeng-Cheng Lv, Jyoti Roy, Karson S Putt, et al.
Molecular Cancer Therapeutics|December 17, 2016
Evaluation of Nonpeptidic Ligand Conjugates for the Treatment of Hypoxic and Carbonic Anhydrase IX-Expressing CancersPeng-Cheng Lv, Jyoti Roy, Karson S Putt, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Expert Opinion on Therapeutic Patents|November 20, 2014
EGFR-binding peptide: a patent evaluation of WO2014002836Peng-Cheng Lv, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|February 3, 2015
Nitroimidazole derivatives: a patent review of US 2014/0141084 A1Peng-Cheng Lv, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|December 16, 2016
Tyrosyl-tRNA synthetase inhibitors: a patent reviewJuan Sun, Peng-Cheng Lv, Hai-Liang Zhu
Current Medicinal Chemistry|December 3, 2014
Recent advances of p53-MDM2 small molecule inhibitors (2011-present)Peng-Cheng Lv, Juan Sun, Hai-Liang Zhu
Bioconjugate Chemistry|July 1, 2016
Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing CancersPeng-Cheng Lv, Karson S Putt, Philip S Low
Current Topics in Medicinal Chemistry|September 19, 2019
Recent Progress in the Development of Small Molecule c-Met InhibitorsPeng-Cheng Lv, Yu-Shun Yang, Zhong-Chang Wang
Current Medicinal Chemistry|November 3, 2016
Recent Advances in the Design and Synthesis of c-Met Inhibitors as Anticancer Agents (2014-Present)Peng-Cheng Lv, Zhong-Chang Wang, Hai-Liang Zhu
Archiv Der Pharmazie|March 17, 2010
Design, synthesis, and pharmacological investigation of iodined salicylimines, new prototypes of antimicrobial drug candidatesSuo-Ping Xu, Peng-Cheng Lv, Lei Shi, et al.
Molecular Pharmaceutics|April 5, 2016
Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic TumorsPeng-Cheng Lv, Jyoti Roy, Karson S Putt, et al.
Molecular Cancer Therapeutics|December 17, 2016
Evaluation of Nonpeptidic Ligand Conjugates for the Treatment of Hypoxic and Carbonic Anhydrase IX-Expressing CancersPeng-Cheng Lv, Jyoti Roy, Karson S Putt, et al.
Pageof 7